In line with these results, we found a decreased rate of naïve T cells (CD45RA+/CCR7+) and an increased frequency of effector memory T cells (CD45RA−/CCR7−) in the tumor microenvironment compared to PBMC of cancer patients. The gene discussed is CCR7; the disease is neoplasm.